Abhijit Rath, PhDInstructor of Molecular Oncology
|
Our lab's interest can broadly be divided into two categories.
i. Investigating mechanism of mismatch repair (MMR) deficiency in solid tumors. Primarily, our lab is interested in discovering genetic causes of early-onset colorectal cancer. Specifically, we focus on understanding the disease mechansim in patients who present with tumors exhibiting clinical hallmarks of mismatch repair deficiency, yet lack diagnostic proof of hereditary pathogenic changes in the canonical MMR genes or their sporadic inactivation. These patients are categorized as having an unexplained mismatch repair deficiency (uMMRd) or Lynch-like syndrome (LLS). A molecular explanation for LLS patients is often absent. We aim to identify genes which are of diagnostic significance for LLS-suspect patient population.
This work is currently supported by the Chris4Life Colorectal Cancer Alliance Early Career Investigator Award Grant.
ii. Facilitating CRISPR based functional genomics approaches to allow high throughput precise gene editing. This primarily involves modulation of intrinsic DNA repair pathways to allow highly efficient targered edit either by use of inhibitors or augmentation with biological modulators.
Degree | Institution | Major |
---|---|---|
BVSc & AH | Orissa University of Agriculture & Technology | Veterinary Science and Animal Husbandry |
PhD | LSU Health Shreveport | Biochemistry and Molecular Biology |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Postdoctoral | UConn School of Medicine | Genetic Predisposition to Colorectal Cancer |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Full Scholarship for the “Workshop on 3D Genome Mapping Technology-ChIA-PET” | The Jackson Laboratory |
Carroll Feist Predoctoral Research Fellowship | LSU Health Shreveport |
Outstanding Biochemistry Graduate Student Award (Second Place) | LSU Health Shreveport |
First Place in Ray A. Barlow Excellence in Cancer Research Award in Barlow Symposium | LSU Health Shreveport |
Jason A. Cardelli Award for Excellence in Cancer Research | LSU Health Shreveport |
My current research focuses on modeling Lynch syndrome (LS)/Lynch-like syndrome (LLS) associated gene variants in human embryonic stem cells using CRISPR-Cas gene editing. We aim to gather variant specific functional data to better inform the clinical diagnosis and stratification of LS/LLS patients.
Over the course of the last few years, we have optimized CRISPR based genome engineering to serve as a highly efficient tool to site-specifically incorporate genomic single nucleotide variant change. We aim to improve the throughput of this powerful reverse genetic approach for large scale functional genomics studies and lessen the existing technical constraints. Specifically, we aim to explore novel methodologies to improve homology directed repair outcomes for CRISPR-Cas induced DNA double-strand breaks.
We also aim to study the putative genetic modifiers of mismatch repair by modeling them in human cells and functionally evalutate them for preservation of mismatch repair function.
i. Hereditary basis of unexplained MMR deficiency
Journal Articles
-
Functional and phenotypic consequences of an unusual inversion in MSH2.
Familial cancer 2023 Nov;
-
Loss of mismatch repair promotes a direct selective advantage in human stem cells.
Stem Cell Reports 2022 Dec;17P2661-2673
-
A calibrated cell-based functional assay to aid classification of MLH1 DNA mismatch repair gene variants.
Human Mutation (Editor's choice) 2022 Dec;43(12):2295-2307
-
Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways.
Nature communications 2019 Sep;10(1):4296
-
Functional Interrogation of Lynch Syndrome Associated MSH2 Missense Variants via CRISPR-Cas9 Gene Editing in Human Embryonic Stem Cells.
Human mutation (Editor's choice) 2019 Jun;
-
Fidelity of end joining in mammalian episomes and the impact of Metnase on joint processing.
BMC molecular biology 2014 Mar;156
-
Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy.
Genes & cancer 2013 Jan;4(1-2):39-53
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
A calibrated cell-based functional assay to aide classification of MLH1 DNA mismatch repair gene variants | Talk | The International Society for Gastrointestinal Hereditary Tumors (InSiGHT) | 2022 | New Jersey |